134 related articles for article (PubMed ID: 22168024)
1. [Antibacterial therapy of severe intra-abdominal infections].
Boĭko VV; Ivanova IuV
Klin Khir; 2011 Sep; (9):43-6. PubMed ID: 22168024
[TBL] [Abstract][Full Text] [Related]
2. [Comparative estimation of the application efficacy for ceftriaxon and Hepacef combi preparations in the abdominal infection treatment].
Boĭko VV; Ivanova IuV
Klin Khir; 2012 Jan; (1):30-2. PubMed ID: 22642085
[TBL] [Abstract][Full Text] [Related]
3. [Mepenam application for prophylaxis and treatment of purulent complications of an acute destructive pancreatitis].
Nychytaĭlo MIu; Bulyk II
Klin Khir; 2011 Dec; (12):22-4. PubMed ID: 22432188
[TBL] [Abstract][Full Text] [Related]
4. [Enhancing efficacy of the primary antibacterial therapy for intraabdominal infections].
Boĭko VV; Ivanova IuV
Klin Khir; 2012 Nov; (11):54-8. PubMed ID: 23272388
[TBL] [Abstract][Full Text] [Related]
5. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
[TBL] [Abstract][Full Text] [Related]
6. Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Rice DA; Kaniga K; Lee M; Redman R
Int J Antimicrob Agents; 2013 Apr; 41(4):388-92. PubMed ID: 23410792
[TBL] [Abstract][Full Text] [Related]
7. [Microbiological and resistance profiles of community acquired and nosocomial intra abdominal infections in surgery of National Hospital Guillermo Almenara, Lima, Peru].
Revoredo Rego F; Huamán Egoávil E; Zegarra Cavani S; Auris Mora H; Valderrama Barrientos R
Rev Gastroenterol Peru; 2016; 36(2):115-22. PubMed ID: 27409087
[TBL] [Abstract][Full Text] [Related]
8. Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections.
Chao CM; Chen CC; Huang HL; Chuang YC; Lai CC; Tang HJ
PLoS One; 2016; 11(12):e0167522. PubMed ID: 27907197
[TBL] [Abstract][Full Text] [Related]
9. [Application of gepacef comby for an acute surgical diseases of organs of the hepatopancreatobiliary zone].
Pesotskiĭ ON
Klin Khir; 2013 Jan; (1):40-3. PubMed ID: 23610944
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.
Cohen-Wolkowiez M; Poindexter B; Bidegain M; Weitkamp JH; Schelonka RL; Randolph DA; Ward RM; Wade K; Valencia G; Burchfield D; Arrieta A; Mehta V; Walsh M; Kantak A; Rasmussen M; Sullivan JE; Finer N; Rich W; Brozanski BS; van den Anker J; Blumer J; Laughon M; Watt KM; Kearns GL; Capparelli EV; Martz K; Berezny K; Benjamin DK; Smith PB;
Clin Infect Dis; 2012 Dec; 55(11):1495-502. PubMed ID: 22955430
[TBL] [Abstract][Full Text] [Related]
11. [Application of combined antibacterial preparations in the treatment of surgical intra-abdominal infections].
Nichitaĭlo ME; Bulik LM
Klin Khir; 2013 Jan; (1):37-9. PubMed ID: 23610943
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
Lucasti C; Popescu I; Ramesh MK; Lipka J; Sable C
J Antimicrob Chemother; 2013 May; 68(5):1183-92. PubMed ID: 23391714
[TBL] [Abstract][Full Text] [Related]
13. Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.
Mazuski JE
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-49-69. PubMed ID: 23577497
[TBL] [Abstract][Full Text] [Related]
14. Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
Bartoletti M; Tedeschi S; Pascale R; Raumer L; Maraolo AE; Palmiero G; Tumietto F; Cristini F; Ambretti S; Giannella M; Lewis RE; Viale P
Int J Antimicrob Agents; 2018 Mar; 51(3):516-521. PubMed ID: 29410250
[TBL] [Abstract][Full Text] [Related]
15. Editorial commentary: effectiveness or efficacy: which study to evaluate antibiotics in neonates?
Jacqz-Aigrain E
Clin Infect Dis; 2012 Dec; 55(11):1503-4. PubMed ID: 22955433
[No Abstract] [Full Text] [Related]
16. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
Basoli A; Meli EZ; Mazzocchi P; Speranza V
Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
[TBL] [Abstract][Full Text] [Related]
19. Guideline-Concordant Versus Discordant Antimicrobial Therapy in Patients With Community-Onset Complicated Intra-abdominal Infections.
Huang LL; Van Schooneveld TC; Huang RD; Olsen KM; Rupp ME; Gross AE
Infect Control Hosp Epidemiol; 2016 Jul; 37(7):855-8. PubMed ID: 27020310
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011.
Hawser S; Hoban DJ; Badal RE; Bouchillon SK; Biedenbach D; Hackel M; Morrissey I
J Chemother; 2015 Feb; 27(2):67-73. PubMed ID: 24548089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
